Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea
Clinical trial NCT03079531 · COMPLETED
Trial details
- NCT number
- NCT03079531
- Sponsor
- Anne Chang
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-21
- Primary completion
- 2019-01-25
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.